Parathyroid Hormone (PTH)-Related Protein(1-36) Is Equipotent to PTH(1-34) in Humans

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 199-208

  Everhart Caye, Maria ^b   Inzucchi, Silvio E ^b   Guinness Henry, Jean ^b   Mitnick, Mary Ann ^b   Stewart, Andrew F ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIUM ION; CYCLIC AMP; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS;

ADULT; ARTICLE; CALCIUM EXCRETION; CALCIUM HOMEOSTASIS; CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERCALCEMIA; KIDNEY TUBULE ABSORPTION; MALE; NORMAL HUMAN; OSTEOLYSIS; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; CALCITRIOL; CALCIUM; CYCLIC AMP; FEMALE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; PHOSPHORUS; PROTEINS; TERIPARATIDE;

EID: 0030029166     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.1.8550752     Document Type: Article

References (51)

1. Halloran BP, Nissenson RA. 1992 Parathyroid Hormone-Related Protein: Normal Physiology and Its Role in Cancer, Boca Raton, FL: CRC Press.
2. Burtis WJ, Yang KH, Stewart AF. 1995 Nonparathyroid hypercalcemia. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism, ed 2. Philadelphia: J.B. Lippincott Co.; 520-532.
3. Strewler GJ, Nissenson RA. 1993 Parathyroid hormone-related protein. In: Favus M, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. New York: Raven Press; 61-63.
4. Stewart AF. 1993 Humoral hypercalcemia of malignancy. In: Favus M, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press; 169-173.
5. Martin TJ, Moseley TJ. 1995 Parathyroid hormone-related protein. In: DeGroot LJ, ed. Endocrinology, ed 3. Philadelphia: W.B. Saunders; 967-977.
6. Stewart AF, Insogna KL, Broadus AE. 1995 Malignancy-associated hypercalcemia. In: DeGroot LJ, ed. Endocrinology, 3rd ed. Philadelphia: W.B. Saunders; 1061-1074.
7. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. 1980 Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and non-humoral groups. N Engl J Med. 303:1377-1383.
8. Schilling T, Pecherstorfer M, Blind E, Leidig G, Ziegler R, Raue F. 1993 Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxy-vitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab. 76:801-803.
9. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. 1994 Calcitriol production in hypercalcemic and normocalcemic patients with non-hodgkin lymphoma. Ann Intern Med. 121:633-640.
10. Godsall JW, Burtis WJ, Insogna KL, Broadus AE, Stewart AF. 1986 Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy. Recent Prog Horm Res. 40:705-750.
11. Powell D, Singer FR, Murray TM, Minkin C, Potts, Jr, JT. 1973 Non-parathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 289:176-181.
12. Ralston SH, Fogelman I, Gardner MD, Dryburgh FJ, Cowan RA, Boyle IT. 1984 Hypercalcaemia of malignancy: evidence for a non-parathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci. 66:187-191.
13. Bonjour J-P, Philippe J, Guelpa G, et al. 1988 Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone. 9:123-130.
14. Ralston SH, Boyce BR, Cowan RA, Gardner MD, Fraser WD, Boyle IT. 1989 Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy. J Bone Miner Res. 4:103-111.
15. Stewart AF, Vignery A, Silvergate A, et al. 1982 Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 55:219-227.
16. Silverberg SJ, Gartenberg F, Jacobs TP, et al. 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab.80:723-728.
17. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev. 14:690-709.
18. 3 biosynthesis in athymic mice. Am J Physiol. 256:E309-E314.
19. 3 production. Endocrinology. 124:2057-2062.
20. Orloff JJ, Reddy DR, dePapp AE, Yang KH, Soifer NE, Stewart AF. 1994 Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 15:40-60.
21. Broadus AE, Mangin M, Ikeda K, et al. 1988 Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. N Engl J Med. 319:556-563.
22. Yang KH, dePapp AE, Soifer NS, et al. 1994 Parathyroid hormone-related protein: evidence for transcript- and tissue-specific post-translational processing. Biochemistry. 33:7460-7469.
23. Soifer NE, Dee KE, Insogna KL, et al. 1992 Parathyroid hormone-related protein: evidence for secretion of a novel mid-region fragment by three different cell types. J Biol Chem. 267:18:236-243.
24. Rabbani SA, Haq M, Goltzman D. 1993 Biosynthesis and processing of endogenous parathyroid hormone related peptide (PTHRP) by rat Leydig cell tumor H-500. Biochemistry. 32:4931-4937.
25. Caufield MP, McKee RL, Goldman ME, et al. 1990 The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocrinology. 127:83-87.
26. Abou-Samra A-B, Uneno S, Jueppner H, et al. 1989 Non-homologous sequences of parathyroid hormone and the parathyroid hormone related peptide bind to a common receptor on ROS 17.28 cells. Endocrinology. 125:2215-2217.
27. 37 in PTHrP prevents prohormone processing. J Bone Miner Res. 9[Suppl]:S281.
28. Devi L. 1991 Peptide processing at monobasic sites. In: Fricker L, ed. Peptide Biosynthesis and Processing. Boca Raton, FL: CRC Press; 175-198.
29. Fraher LJ, Hodsman AB, Jonas K, et al. 1992 A comparison of the in vivo biological responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab. 75:417-423.
30. Fraher LJ, Klein K, Marier R, Freeman D, et al. 1995 Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans. J Clin Endocrinol Metab. 80:60-64.
31. Stewart A, Mangin M, Wu T, et al. 1988 A synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest. 81:596-600.
32. Stewart AF, Elliot J, Burtis WJ, Wu T, Insogna KL. 1989 Synthetic parathyroid hormone-like protein (1-74): biochemical and physiological characterization. Endocrinology. 124:642-648.
33. Merendino JJ, Insogna KL, Milstone LM, Broadus AE, Stewart AF. 1986 Cultured human keratinocytes produce a parathyroid hormone-like protein. Science. 231:388-390.
34. Orloff JJ, Ribaudo AE, McKee RL, Rosenblatt M, Stewart AF. 1992 A pharmacological comparison of parathyroid hormone receptors in human bone and kidney. Endocrinology. 131:1603-1611.
35. Orloff JJ, Kats Y, Urena P, et al. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology, in press.
36. Burtis WJ, Brady TG, Orloff JJ, et al. 1990 Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy. N Engl J Med. 322:1106-1112.
37. Orloff JJ, Wu T, Heath HW, Brady T, Brines ML, Stewart AF. 1989 Characterization of canine renal receptors for the parathyroid hormone-like protein associated with humoral hypercalcemia of malignancy. J Biol Chem. 264: 6097-6103.
38. 2D not requiring high performance liquid chromatography. J Clin Endocrinol Metab. 58:91-98,
39. Broadus AE. 1979 Nephrogenous cyclic AMP as a parathyroid function test. Nephron. 23:136-141.
40. Mallette LH, Kirkland JL, Gagel RF, Law, Jr, WM, Heath III H. 1988 Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. J Clin Endocrinol Metab. 67:964-972.
41. Cosman F, Shen V, Herrington B, Lindsay R. 1991 Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay. J Clin Endocrinol Metab. 73:1345-1351.
42. Lindsay R, Nieves J, Henneman E, Shen V, Cosman F. 1993 Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Enocrinol Metab. 77:1535-1539.
43. Furlong TJ, Seshadri MS, Wilkinson MR, Cornish CJ, Luttrell B, Posen S. 1986 Clinical experiences with human parathyroid hormone 1-34. Aust NZ J Med. 16:794-798.
44. 3 in the hypercalcaemia associated with the Walker carcinosarcoma 256 in the rat. Med Sci Res. 17:81-82.
45. Insogna KL, Stewart AF, Namnum PA, et al. 1984 Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Endocrinology. 114:888-896.
46. Walker AT, Stewart AF, Korn EA, Shiratori T, Mitnick MA, Carpenter TO. 1990 Effect of parathyroid hormone-like peptides on 25-hydroxyvitamin D-1-α-hydroxylase activity in rodents. Am J Physiol. 258:E297-E303.
47. Horiuchi N, Caulfield MP, Fisher JE, et al. 1987 Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science. 238:1566-1568.
48. Wu TL, Soifer NE, Burtis WJ, Milstone LM, Stewart AF. 1991 Glycosylation of parathyroid hormone-related peptide secreted by human epidermal keratinocytes. J Clin Endocrinol Metab. 73:1002-1007.
49. Brandt DW, Burton DW, Gazdar AF, Oie HE, Deftos LJ. 1991 All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography. Endocrinology. 129: 2466-2470.
50. Samuels MH, Veldhuis J, Cawley C, et al. 1993 Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis. J Clin Endocrinol Metab. 76:399-403.
51. Harms HM, Neubauer O, Kayser C, et al. 1994 Pulse amplitude and frequency modulation of parathyroid hormone in early postmenopausal women before and on hormone replacement therapy. J Clin Endocrinol Metab. 78:48-52.